About Institute for Community Living Inc
Services Offered
Type of Care:
Substance use treatment Mental health treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.):
Outpatient
Facility Type:
Outpatient mental health facility
Pharmacotherapies:
Chlorpromazine Fluphenazine Haloperidol Loxapine Perphenazine Pimozide Prochlorperazine Thiothixene Thioridazine Trifluoperazine Aripiprazole Asenapine Brexpiprazole Cariprazine Clozapine IIoperidone Lurasidone Olanzapine Olanzapine/Fluoxetine combination Paliperidone Quetiapine Risperidone Ziprasidone Nicotine replacement Non-nicotine smoking/tobacco cessation Antipsychotics used in treatment of SMI
Treatment Approaches:
Cognitive behavioral therapy Cognitive remediation therapy Couples/family therapy Dialectical behavior therapy Group therapy Integrated Mental and Substance Use Disorder treatment Individual psychotherapy Telemedicine/telehealth therapy
Emergency Mental Health Services:
Crisis intervention team
Facility Operation (e.g., Private, Public):
Private non-profit organization
Payment Assistance Available:
Payment assistance (check with facility for details) Sliding fee scale (fee is based on income and other factors)
Assessment/Pre-treatment:
Screening for tobacco use
Recovery Support Services:
Housing services Mentoring/peer support
Education and Counseling Services:
Smoking/vaping/tobacco cessation counseling
Facility Smoking Policy :
Smoking not permitted
Age Groups Accepted:
Children/Adolescents Young Adults Adults Seniors
Language Services:
Spanish Other languages (excluding Spanish)
Other Languages:
French
Facility Vaping Policy:
Vaping not permitted
Ancillary Services:
Assertive community treatment Assisted Outpatient Treatment Family psychoeducation Intensive case management Supported housing Vocational rehabilitation services Case management service Suicide prevention services Education services
